Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continued Access Protocol: A Prospective, Multicenter, Single-Arm, Observational Study of the Safety and Clinical Performance of RES (Regenerative Epithelial Suspension) Prepared With the ReCell® Device Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries

NCT03333941 is registered in ClinicalTrials.gov with Avita Medical as lead sponsor.

NCT NCT03333941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03333941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continued Access Protocol: A Prospective, Multicenter, Single-Arm, Observational Study of the Safety and Clinical Performance of RES (Regenerative Epithelial Suspension) Prepared With the ReCell® Device Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
Lead sponsor
Avita Medical
Phase
Observational
Overall status
Completed
Start date
October 26, 2017
Completion date
May 8, 2019
Enrollment
76 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

burns